Eos Biotechnology

Eos Biotechnology was developing therapeutic antibodies for cancer, angiogenesis, and inflammation.

2 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Mr. Robert WilliamsonEmploymentEos Biotechnology
Reported^{2Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Position or object indicated by the source: “President and COO.”
PDL BioPharmaOwnershipEos Biotechnology
Amount not specifiedApril 2003Reported^{1Eos Biotechnology - 2026 Company Profile & Team - Tracxntracxn.com}

Sources

1.
Eos Biotechnology - 2026 Company Profile & Team - Tracxn
Web pagetracxn.com
View original ↑ Back to text
2.
Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text